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Background: Recent studies have suggested that cognitive functions in patients with 
neurocognitive disorders have a significant role in the pathogenic mechanisms of frailty. 
Although pre-frailty is considered an intermediate, preclinical state, epidemiological 
research has begun to dislodge cognition and frailty into their specific subcomponents 
to understand the relationship among them. We aim to analyse the possible association 
between pre-frailty and neuropsychological variables to outline which factors can con-
tribute to minor and major neurocognitive disorders.
Methods: 60 subjects complaining of different cognitive deficits underwent a deep-
in-wide frailty and neuropsychological assessment. We conducted three multiple 
linear regression analyses adjusted for a combination of demographic measures and 
involving several neuropsychological–behavioural parameters selected by the literature 
on physical frailty.
results: We found a significant association between frailty—as measured by the multi-
dimensional prognostic index (MPI)—and action monitoring and monetary gain (cognitive 
domain), depression and disinhibition (behavioural domain). Moreover, an association 
between MPI and impaired awareness for instrumental activities disabilities exists.
conclusion: We propose a novel framework for understanding frailty associated with 
metacognitive–executive dysfunction.
Keywords: pre-frailty, mild cognitive impairment, comprehensive geriatric assessment, alzheimer’s disease, 
executive dysfunction
inTrODUcTiOn
Frailty is a complex and heterogeneous clinical syndrome. It is described by augmented vulnerability 
resulting from age-related decline across several body organs and physiological systems (1, 2). Frailty 
leads to a decrease in the ability to remain independent and to maintain a good quality of life (3). 
Moreover, it increases the risk of disability and mortality (3). The frailty syndrome has principally 
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been explored by focussing on the physical domain, mostly rely-
ing on signs and symptoms such as muscle weakness, sedentary 
behaviour, slow gait speed, and weight loss (1). Frailty has also 
been involved in general cognitive decline and impaired global 
cognition (4).
Canevelli and colleagues (5) have recently emphasised some 
criticalities of these studies: (a) the overwhelming majority 
of them have assessed frailty using the criteria proposed by 
Fried and colleagues (1), primarily aimed at describing the 
physical dimension of frailty; (b) most of these researches 
adopted only a measure of global cognitive functioning, mostly 
assessed by the Mini Mental State Examination [MMSE; (6)] 
to assess cognition, in absence of a comprehensive neuropsy-
chological evaluation; (c) finally, the sample populations 
were mainly composed of community-dwelling older adults, 
preventing the applicability of results to other types of patients. 
The limitations of those studies have also been previously 
reported (7).
The overall concept of examining the specific cognitive cor-
relates of frailty is interesting and may indeed shed light on a 
more comprehensive model of frailty that details a specific 
neuropsychological profile. Interestingly, the most novel evidence 
comes from a small number of studies aimed at examining the 
association between specific cognitive functions and physical 
frailty (5). In particular, Canevelli and colleagues (5) pointed out 
a significant impairment of attention and executive functions. 
Importantly, literature has shown that the executive function 
and attention domains are related to frailty, while gait speed 
or grip strength are the components of frailty most strongly 
associated with cognition (8–20). O’Halloran and colleagues (8) 
recently stated that pre-frail and frail individuals seem less able 
than robust subjects in the “Sustained Attention to Response 
Task” (SART). Even if these studies represent a first important 
attempt to describe the association between cognitive functions 
and physical frailty, there is still the need to assess frailty with a 
multidimensional approach (21–23).
Although executive function and attention domains may be 
related to physical frailty, no previous studies have investigated 
the role of different neuropsychological domains by carrying out 
a multidimensional assessment of frailty. In line with this, the 
multidimensional prognostic index (MPI) currently represents 
one of the suggested methods for a comprehensive assessment 
of frailty (24–26).
The aim of this study is to investigate whether pre-frailty, 
measured through the MPI, might be influenced by cognitive–
behavioural measures in individuals with minor and major 
neurocognitive disorders [DSM-5; (27)], from mild cognitive 
impairment (MCI) likely due to Alzheimer’s disease (AD), to 
mild AD patients (28). For this reason, we conducted three 
multiple linear regression analyses to study: (1) the role of 
global cognitive functioning and specific cognitive variables 
(selective attention, episodic memory, language comprehen-
sion, and reasoning in the visual modality); (2) the role of 
metacognitive executive functions, such as response monitor-
ing; and (3) the relationship with mood changes, quality of life, 
and awareness of independence for daily living instrumental 
activities.
MaTerials anD MeThODs
Participants
All the outpatients were enrolled at the Neurology Division of 
the “Città della Scienza e della Salute” Hospital and the Martini 
Hospital, both in Turin (Italy).
Participants were included in the study if they had: (a) minor 
or major neurocognitive disorders (27), such as MCI-likely 
due to AD and mild AD. On the other hand, participants were 
excluded from the study if they had: (a) dysthymia or major 
depressive disorder, based on DSM-5 criteria (27); (b) A MMSE 
score <20, given that the neuropsychological measurement 
is not as reliable when problems of language comprehension 
occur; (c) were taking medications that could substantially 
impact cognitive functioning. CSF diagnosis that did not pro-
vide in vivo evidence of Alzheimer’s pathology was considered 
exclusion criterion.
The patients underwent a complete neurological examina-
tion and neuroradiological investigations (MRI and FDG-PET). 
All the patients underwent lumbar puncture with cerebrospinal 
fluid measurement of 1-42 beta-amyloid, phospho-Tau, and 
total-Tau (Innogenetics kits, Ghent, Belgium).
assessment of Frailty
Several operational definitions have been proposed to assess 
frailty in the elderly (29). Although this variability might be 
acceptable from a public health perspective, the identification of 
a gold standard measure might still be important to obtain. To 
date, frailty is still detected using different instruments and none 
of them has been able to prevail as superior to the others (29).
An index originally conceived and designed in the Italian 
general practice setting for the evaluation of chronic mul-
tipathological conditions was initially used to screen the par-
ticipants’ levels of frailty (30). The scale for the Evaluation of 
the frailty elderly (Scheda di Valutazione dell’Anziano Fragile,1 
SVAFRA) is a “multiaxial” score, interpreted according to the 
principles of the complexity theory in medicine and healthcare 
(30). This scale is a useful tool in case of multiaxial assessment 
in the setting of primary care (31), especially for its ability to 
combine technical skills, synthesis of information, and care-
management suggestions (30, 31). SVAFRA was used for the 
first “Cognitive survey on the frailty of elderly people in Italy,” 
which was attended by 34 Primary Care Physicians and 521 
elderly recruited in Veneto, Lazio, and Sicily (32).
According to the authors, frailty is determined by issues per-
taining at least one of the following evaluative dimensions (30): 
physical and mental health; physical and cognitive–behavioural 
disabilities; patient management considering the care burden; 
family and socio-environmental background. For each axis, 
determinants can assume a value between 0 (no deficiencies) and 
3 (very serious problems). The level of frailty is then classified 
based on a combination of these four dimensions. A synthetic 
value—regardless of the value previously assigned to the four 
determinants—can also be assigned: F0 (absence of frailty, typical 
1 Frailty in the elderly evaluation sheet.
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of healthy patients); F1 (pre-frailty); F2 (medium frailty); F3 
(severe frailty, typical of severely ill patients); T (extreme frailty, 
typical of terminally ill patients).
Since clinicians needed an outcome instrument with sound 
clinimetric properties (33), frailty was assessed using a compre-
hensive geriatric assessment (CGA), which was considered the 
first-choice tool for evaluating biological, functional, cognitive, 
social, and clinical aspects of elderly subjects, as expressed by 
the Italian Society of Gerontology and Geriatrics (34, 35). The 
MPI was developed from a standardised CGA (26, 35, 36). It 
was originally conceived as a prognostic index of mortality in 
the short- and long-term period based on information obtained 
through the CGA in hospitalised (37) and outpatient settings (38). 
With this index, the prognostic value of negative outcomes and 
related severity are even higher than with the indices calculated 
in the single domains of the rating. The MPI is also considered 
suitable for assessing frailty in the elderly (34–36). Moreover, as 
a cumulative multidimensional index, the MPI allows profes-
sionals to develop a treatment plan (22). In 2013, the European 
Innovation Partnership on Active and Healthy Ageing identified 
98 “good practices” involved in research to reverse or prevent 
frailty (24). As demonstrated by the Marco Polo Initiative, the 
MPI is helpful in identifying frailty elders, providing personalised 
interventions, avoiding drug prescriptions and adverse hospital 
admissions (24, 39).
The MPI includes information on clinical, functional, nutri-
tional, and neuropsychological aspects, as well as polypathology, 
pharmacological treatment, and the social support network 
(22, 25, 26, 35–40). Specifically, the MPI is calculated using 
a mathematical algorithm that includes scores of individual 
profiles obtained from the eight evaluation tools that make up 
the CGA: 1. activity of daily living scale (ADL); 2. instrumental 
activity of daily living scale (iADL); 3. short portable mental status 
questionnaire (to assess cognitive status); 4. cumulative illness rat-
ing scale—comorbidity index (CIRS-CI, to explore comorbidity); 
5. Mini Nutritional Assessment scale (MNA, to assess nutritional 
status); 6. Exton Smith Scale (to evaluate the risk of developing 
pressure sores); 7. polypharmacy; 8. social condition (22, 25, 26, 
35–40).
The numerical index obtained has a value between 0.0 (low-
est risk) and 1.0 (highest risk of mortality) and reports three 
grades of risk of severe prognosis: low risk (MPI value ≤ 0.33), 
moderate risk (MPI value between 0.34 and 0.66), and severe 
risk (MPI ≥ 0.67) (22, 26, 36, 37, 40). Importantly, the effective-
ness of the MPI has recently been verified in population-based 
cohorts. Higher MPI risk scores were associated with more days 
in hospital and with fewer years of survival, across a broad and 
stratified age range (25, 40).
neuropsychological assessment
The neuropsychological evaluation involved a wide assessment 
of global cognitive deterioration using: the CDR (41), the 
Addenbrooke’s Cognitive Examination-Revised version [ACE-R; 
(42)] and, finally, the MMSE (6). Other cognitive domains were 
also assessed with the use of different scales: selective attention 
with Attentional Matrices [AM; (43)], divided attention and 
cognitive shifting with the Trial Making Test [TMT; (43, 44)], 
episodic memory with the Recall of a Short Story test [Babcock; 
(37)], reasoning in the visual modality with Coloured Progressive 
Matrices [CPM-36; (43)], comprehension of spoken language 
with the Token Test [TT; (43, 45)].
Executive functions were analysed with the metacognitive 
version of the Wisconsin Card Sorting Test [m-WCST; (46, 47)]. 
This test is aimed to assess “on-line” metacognitive monitoring 
and control during the execution of the test (46, 47). For each 
card of the test, two questions evaluated “on-line” metacogni-
tive monitoring (“What is your degree of confidence in this 
answer?”) and control (“Do you want to take this response into 
account in your total score?”) (46–48). In the original version 
of Koren’s protocol, the participants were assigned a dollar value 
for each correct response (46–48). In this study, the patients 
received a monetary gain of 10 cents for each correct answer 
and they were deprived of 10 cents for every wrong answer (49). 
As described in our previous work that used the same proce-
dure (49), a set of metacognitive indices were evaluated: “(1) 
accuracy score (AS), the number of correct voluntary answers/
number of voluntary responses; (2) free choice improvement 
(FCI) (accuracy—number of correct responses from forced 
responses)/number of cards presented; (3) global monitoring 
(GM), the number of correct responses—the total number 
of sorts required in the final score; (4) monitoring resolution 
(MR), the gamma correlation calculated between the confi-
dence and correctness of the sorts in the entire test; (5) control 
sensitivity (CS), to what extent the control process depended 
on the monitoring process, indexed by the gamma correlation 
calculated across all sorts between the level of confidence and 
the decision to gamble; (6) monetary gains (MG), given by the 
number of correct voluntary responses—incorrect number of 
voluntary responses” [(49), p. 138].
We verified the subjects’ level of autonomy in basic and 
instrumental activities of daily living (50, 51) and accordingly, 
their quality of life with the Quality of life scale in Alzheimer’s 
disease (QoL-AD)—patient’s subscale (52). Patients were also 
assessed using specific neuropsychiatric rating scales of mood 
changes: apathy and depression with Hamilton Depression 
Rating Scale [HDR-S; (53)], disinhibition and hypomania 
with the Disinhibition Scale and the Mania Scale [DIS-S (54); 
MAS (55)].
Finally, in accordance with what we did in our previous work 
(56), “we followed the classification of Starkstein and colleagues 
(57) who used principal component analysis to subdivide the 
Awareness of Deficit Questionnaire—Dementia scale [AQD 
(58)] into four domains taking into consideration the factors 
loading on each item. One of these factors, identified in terms 
of impaired awareness in instrumental activities of daily living 
(AQD_iADL), was designated as factor 1 by the authors. Factor 
1 embraces 12 items: ‘recalling the date, orienting to new places, 
recalling telephone calls, remembering the location of objects 
at home, understanding conversation and the plot of a movie, 
keeping belongings in order, handling money, doing mental 
calculations, remembering shopping lists and appointments, 
performing clerical work.’ Thus it accounted for most of the vari-
ance and also rated as the earliest functional deficit in patients 
with cognitive impairment” [(56), p. 65]. Since disabilities in 
TaBle 1 | Demographic characteristics and frailty evaluation by a 
comprehensive geriatric assessment.
Maximum 
scores
Mean ± sD cutoff
Demographic characteristics
Gender (male/female) 22/38
Age (years) 66.62 ± 6.80
Schooling (years) 9.28 ± 3.86
Early cognitive symptoms  
complaints (months)
31.15 ± 27.82
Clinical dementia rating scale 0.78 ± 0.44
Multidimentional prognostic index
Activity of daily living scale 8 5.70 ± 0.53 ≥4
Instrumental activity of daily  
living scale
6 6.63 ± 1.55 ≥6
Short portable mental state  
questionnaire
10 2.46 ± 1.63 ≤2
Cumulative illness rating  
scale—comorbidity index
13 1.43 ± 1.42
Mini nutritional assessment 30 21.32 ± 3.62 ≥24
Exton Smith Scale 20 18.80 ± 1.47 ≥15
Polypharmacy 4.12 ± 2.46
Social condition Household
Multidimensional prognostic index 1 0.19 ± 0.12
sVaFraa
F1 % = 97
F2 % = 3
Wherever there is a normative value, the cutoff scores are given in the statistical normal 
direction. Cells in grey indicate the absence of a normative cutoff.
aScheda di Valutazione dell’Anziano Fragile.
4
Amanzio et al. Neuropsychological Correlates of Pre-Frailty
Frontiers in Medicine | www.frontiersin.org November 2017 | Volume 4 | Article 199
instrumental activities of daily living were one of the descriptors 
of frailty used in the Canadian Study on Health and Ageing (59), 
we decided to take it into consideration in our analyses.
Procedures
We implemented a cross-sectional study to explore data col-
lected from our clinical population. Patients were evaluated by 
performing a neuropsychological assessment during a week in 
hospital. The participants were assessed in three experimental 
sessions held 1  day apart and each lasting 1  h, with a view to 
preventing fatigue and lack of adherence to the tasks.
statistical analysis
We performed statistical analyses using SAS/STAT® 9.3 (60, 61). 
The post hoc power was determined using the formula for sample 
size with continuous measures through G*Power 3, which is a 
stand-alone power analysis tool for statistical tests commonly 
used in social and behavioural research (62). The achieved power 
with a sample size of 60 was estimated to provide a minimum of 
70% power at a 5% level of significance (two-sided) to detect a 
medium effect (r2 = 0.2).
To study whether the level of the MPI index could be 
associated with cognitive and behavioural measurements, we 
conducted three multiple linear regression analyses adjusted for 
age, gender, and schooling. Normality assumption distribution of 
linear regression model residuals was evaluated by means of the 
Kolmogorov–Smirnov test.
Importantly, the selection of the three models was performed 
in line with the results obtained in the literature on physical 
frailty. In particular, frailty has been previously associated 
with general cognitive decline, impaired global cognition, and 
memory (5, 8, 18). Moreover, executive function and attention 
domains have been consistently related to frailty (8–10, 12–20). 
Finally, the association between physical frailty and the per-
formance at the SART test (8) seems to suggest that pre-frail 
and frail people might be impaired in response monitoring.
The final selected models considered the MPI as the depend-
ent variable and the following as independent variables:
•	 Model (1) to address the role of global cognitive functioning 
and specific cognitive variables (selective attention, episodic 
memory, language comprehension, and reasoning in the visual 
modality): ACE-R, MA, BABCOCK, TT and CPM-36;
•	 Model (2) to study the role of metacognitive executive func-
tions with m-WCST: FCI, GM, MR, and MG;
•	 Model (3) to investigate the relationship with mood changes, 
quality of life and awareness of autonomy in instrumental 
activities of daily living: HDR-S, MAS, DIS-S, QOL-AD, and 
AQD_iADL.
resUlTs
Over a 24-month period, 72 patients—complaining of different 
cognitive deficits and presenting for the first time at the out-dep 
of our clinics—were evaluated with the overall neuropsycho-
logical assessment. After a month, based on CSF analysis results, 
only subjects with an AD-compatible liquor were included in 
the experimental sample. As a result, 12 patients were excluded, 
while 60 subjects were enrolled. Based on the exclusion criterion, 
12 patients were excluded, while 60 subjects (M/F  =  22/38; 
mean age ± SD = 69.6 ± 6.8 years) were enrolled (see Table 1 
for demographic and clinical data). In particular, 24 MCI due to 
AD patients according to the CSF analysis, were included in the 
study. For those patients with major neurocognitive disorders, 
the CSF diagnosis provided in  vivo evidence of Alzheimer’s 
pathology for 36 patients. The neuropsychological assessment 
reflected the diagnoses made by the CSF (see Table 2 and Table S1 
in Supplementary Material), biomarkers and neurological exams. 
Fifty-six of the 60 patients obtained a CDR score of between 0 and 
1 attesting a low level of cognitive impairment.
Prevalence of Frailty status
As regard the CGA evaluation, the patients fell within the 
lowest MPI range, attesting a low risk of severe prognosis. 
Considering the SVAFRA index, 97% of all patients were clas-
sified as pre-frail, and 3% with medium frailty.
association between Frailty and 
neuropsychological Variables
After adjusting the analysis for age, gender, and schooling, 
the MPI index scores were influenced by MR and MONEY in 
model 2, and by HDR-S, DIS-S, and AQD_iADL in model 3. 
On the contrary, the level of pre-frailty measured through the 
MPI index was not influenced by global cognition, memory, 
TaBle 2 | Neuropsychological and neuropsychiatric assessment synopsis.
Maximum 
scores
Mean ± sD cutoff
neuropsychological assessment
Mini-mental state examination 30 25.02 ± 2.85 ≥24
Addenbrooke’s cognitive 
examination—revised version
100 69.57 ± 12.60 ≥82
Attentional matrices 60 30.52 ± 9.91 ≥31
Trial making test A 500 110.73 ± 82.92 ≤94
Trial making test B 500 297.18 ± 158.12 ≤283
Trial making test B-A 194.92 ± 127.11 ≤187
Babcock 16 6.22 ± 3.72 ≥4.75
Coloured progressive matrices-36 36 22.17 ± 7.26 ≥18.96
Token test 36 30.21 ± 3.61 ≥32.69
Wisconsin card sorting test %  
correct answers
52.59 ± 15.44 ≥37.1
Wisconsin card sorting test %  
perseverative errors
34.34 ± 14.95 ≤42.7
Wisconsin card sorting  
test—metacognitive version
Accuracy score 0.03 ± 0.11
Free choice improvement −1.17 ± 4.98
Global monitoring −20.13 ± 14.29
Monitoring resolution 0.19 ± 0.24
Control sensitivity −0.04 ± 0.58
Monetary gains 2.37 ± 1.93
neuropsychiatric assessment
Quality of life scale in Alzheimer’s 
disease—patient module
39 17.90 ± 8.01
Hamilton depression rating scale 67 10.95 ± 7.47 ≤7
Disinhibition scale 96 9.40 ± 6.95 ≤16.9
Mania scale 44 2.62 ± 3.57 ≤15
Awareness of deficit questionnaire—
dementia scale for instrumental  
activity domain
16 3.20 ± 8.22 ≤4
Wherever there is a normative value, the cutoff scores are given in the statistical normal 
direction. Cells in grey indicate the absence of a normative cutoff.
TaBle 3 | Effect of the independent variables on the multidimensional prognostic index estimated by the univariate and multiple linear regression analyses.
crude estimates adjusted estimates
Model independent variables β p se β p se
1 Addenbrooke’s cognitive examination—revised version −0.20 0.18 0.001 −0.03 0.87 0.001
Attentional matrices −0.36 0.02 0.002 −0.29 0.11 0.002
Babcock −0.05 0.75 0.005 0.09 0.60 0.006
Token test −0.12 0.43 0.005 −0.01 0.95 0.005
Coloured progressive matrices-36 −0.27 0.06 0.002 −0.14 0.44 0.003
Model significance R2 = 0.2056, F = 1.42 p = 0.2137
2 Free choice improvement 0.07 0.60 0.003 0.03 0.84 0.003
Global monitoring −0.07 0.60 0.001 0.11 0.42 0.001
Monitoring resolution 0.33 0.02 0.075 0.37 0.01 0.073
Monetary gains −0.21 0.14 0.009 −0.30 0.04 0.009
Model significance R2 = 0.2863, F = 2.46 p = 0.0322
3 Hamilton depression rating scale 0.49 <0.00 0.002 0.41 <0.00 0.002
Mania scale 0.09 0.52 0.005 −0.25 0.07 0.005
Disinhibition scale 0.50 <0.00 0.002 0.52 <0.00 0.003
Quality of life scale in Alzheimer’s disease −0.21 0.17 0.002 −0.01 0.91 0.002
AQ-D scale for instrumental activity domain −0.14 0.35 0.002 −0.30 0.02 0.002
Model significance R2 = 0.4980, F = 5.46 p < 0.0001
In multivariable analyses standardised coefficients are adjusted for age, gender, and schooling. Values in bold italics showed a statistically significant association (p < 0.05).
AQ-D, Awareness Questionnaire in Dementia.
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language comprehension, non-verbal reasoning (in model 1), 
or by QOL-AD (in model 3, see Table 3).
The normality distribution assumption of residuals in each 
model is fulfilled (Kolmogorov–Smirnov test > 0.05).
DiscUssiOn
The aim of this study was to analyse the association among a 
multidimensional assessment of frailty, executive dysfunc-
tion and specific cognitive and behavioural variables using an 
overall neuropsychological battery. Our findings suggested 
that pre-frailty was associated with metacognitive executive 
dysfunction, in terms of action monitoring in MCI-likely due 
to AD and AD patients. Specifically, we observed a significant 
association between the MPI index and MR underlying the 
role of MR, where patients fail to distinguish between correct 
and incorrect sorts. The results obtained were specific and not 
influenced by other cognitive functions such as global cognition, 
memory, language comprehension, and non-verbal reasoning, 
with the exception of the selective attention task that reached 
a near significance level. Moreover, taking the MPI scores into 
account, we observed an involvement of mood changes in terms 
of depression, apathy, and disinhibition and a reduced awareness 
of iADL, while the relationship with hypomania was near to the 
significance value.
Although we considered patients with different degrees of 
cognitive impairment, our sample was homogeneous in terms 
of the etiopathogenesis, MPI level of risk, comorbidity with 
physical illness, somatic complaints, laboratory tests, and the 
level of mood changes. Moreover, we excluded all patients with 
neurological diseases other than AD. Most importantly, our 
attempt to consider these kinds of patients in the same sample 
was justified by the regression analysis approach we used and by 
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the international guidelines on ageing that consider patients with 
cognitive impairment to lie on a continuum between MCI and 
mild AD (28, 63, 64).
Based on the results we obtained, there appear to be no 
straightforward associations between pre-frailty and specific 
aspects of neuropsychological functioning such as global cogni-
tion, long-term verbal memory, language comprehension, and 
non-verbal reasoning. As underlined by a review on cognitive 
impairment and frailty, not all cognitive domains may become 
impaired simultaneously (7). Although Canevelli et al. (5) have 
described a possible association between memory and physical 
frailty, other studies have found that memory does not seem to 
be clearly associated with frailty [i.e., Ref. (17, 65)]. As far as we 
are aware, no previous studies have addressed the association 
between frailty and language comprehension on the one hand, 
and frailty and non-verbal reasoning on the other (18). Moreover, 
we found no generalised cognitive impairment as a prerequisite 
of pre-frailty in our patients. Nevertheless, previously researches 
have reported a substantial association between frailty and 
cognitive deterioration (5, 7, 18, 66), although the phenotype 
model often used in these does not include cognitive function 
in its definition (1). Despite these evidences—as previously sug-
gested by Robertson and colleagues (7)—statistical analyses of 
the proposed components of frailty suggest that, while energy, 
mobility, mood, physical activity, and strength aggregate as one 
concept, cognitive function does not clearly correlate with this 
and therefore may not be part of the frailty syndrome (67, 68). 
Furthermore, a study of AD patients found that 22% had no indi-
cations of frailty (69, 70). Indeed, Fougère and colleagues in their 
review concluded that “it seems most useful, therefore, to treat 
frailty and cognitive impairment as related but distinct concepts 
that frequently co-occur” [(71), p. 3].
Notably, the assessment of executive dysfunction should 
be seen as an important early predictor of cognitive frailty (9), 
since these problems may appear as the first cognitive changes 
in MCI patients (72), with concomitant iADL difficulties (73). 
Indeed, the early identification of executive impairments may 
be helpful for predicting the long-term functional outcome (74). 
Interestingly, O’Halloran and colleagues (8) recently stated that 
pre-frail and frail individuals seem to make more commission 
errors and omissions than robust subjects on the SART that 
evaluates the ability to sustain attention for a long time with a 
response–suppression element (75, 76). This fact suggests that 
they may be impaired in response monitoring, as we have dem-
onstrated through the association between pre-frailty and action 
monitoring using the m-WCST. Indeed, the main predictor at 
this level has been MR, expressed by Koren and colleagues as 
the correlation between the level of confidence expected from 
the response and correctness of the sorts in the entire WCST 
(46–48). In particular, our patients have shown failure to moni-
tor their own performance considering the errors made during 
task execution, in terms of low metacognitive self-awareness. 
Moreover, we have found an association between the MPI and 
monetary gain, which can be interpreted as subjects’ ability to 
benefit from environmental feedback, anticipate the conse-
quences of their future actions and make decisions accordingly. 
In addition, we have also found pre-frailty to be associated with 
an inability to report unsuccessful experiences in iADL through 
the Awareness Questionnaire in Dementia (AQ-D) (56). In 
our previous article concerning impaired awareness of deficits 
in AD and the role of everyday executive dysfunction (56), 
mood orientation changes, inhibition, self-monitoring, and set 
shifting appeared to be important skills for awareness of iADL 
(AQD_iADL) (56). According to this and considering the neural 
substrate, AD patients with impaired awareness showed reduced 
activation in the Mid Cingulate Cortex during an event-related 
fMRI response-inhibition paradigm, compared to subjects aware 
of their deficits (77).
Through our current results we hypothesise that pre-frailty 
may arise by a disruption of the comparator mechanisms 
res ponsible for monitoring behavioural mood changes and 
cognitive disturbances (56). If the executive system does not 
function properly, as frequently described in MCI-likely due to 
AD and AD patients (78), the comparator mechanism does not 
detect incongruities between the previous and the actual state of 
behaviour/performance. This phenomenon has been observed as 
an inability: (1) to monitor one’s own performance with reference 
to the impact of errors made during task execution, in terms of 
a reduction in metacognitive self-awareness; and (2) to relate 
fruitless experiences in one’s everyday living through the AQ-D.
The few studies investigating the neuropsychiatric factors 
(79–81) have suggested that “one mechanism underlying the 
link between frailty and cognition may be due to psychological 
factors such as mood. Indeed, mood disorders such as depression 
have been found to be both a risk factor for and a consequence 
of frailty” [(7), p. 847]. In line with this, we observed a role of 
HDR-S scores in pre-frailty condition. The HDR-S actually 
measures mood changes, in terms of apathetic behaviour and 
depressive mood possibly related to prefrontal dysfunctions 
(82). This evidence also suggests a possible role of apathy in 
pre-frailty conditions (83). Interestingly, apathy, disinhibition, 
and metacognitive executive dysfunction appear to be neurally 
inscribed in the same network (84–87). The results we obtained 
proposed the suggestive hypothesis that pre-frailty may be due to 
a possible dysfunction of the medial prefrontal–ventral striatal 
network observed throughout action-monitoring disability, 
mood changes, and reduced awareness of iADL. These findings 
ask for new neuroimaging investigations and replication in a 
larger group of patients.
limitations section
The study here presented has been carefully designed and reached 
its aims; however, some critical aspects have to be outlined. The 
first aspect regards the tools used to assess frailty, which could 
represent a possible confounding factor. In particular, pre-frailty 
is defined by adopting the SVAFRA that may not be considered 
appropriate for stratifying the frailty status of the older person 
and it has been rarely adopted for these purposes. Moreover, 
the MPI was originally conceived as a prognostic index of 
mortality in the short- and long-term period (37) and a recent 
international survey among clinical practitioners on the methods 
to assess frailty in their daily practice (29) did not include MPI 
as a tool to assess frailty. However, as previously expressed by 
Bruyére and colleagues (29), frailty is still detected using different 
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instruments and none of them has been able to prevail as superior 
to the others (29). Second, the results we obtained are not gen-
eralisable for patients with different etiopathogenesis other than 
AD. However, our study is a first attempt to investigate possible 
association between pre-frailty and neuropsychological variables 
in a selected patient population, on the basis of liquor examina-
tion and may be limited to identify pathogenetic mechanisms of 
frailty. This is a cross-sectional study aimed to evaluate a possible 
association between frailty and neuropsychological variables in 
MCI-likely due to AD and AD patients. A longitudinal study 
may be the most correct approach to assess for the presence of 
cognitive disorders many years before the development of frailty 
itself. Further studies will be important to better characterised 
this association over time and replicate these findings in a larger 
group of patients.
cOnclUsiOn
This study represents a first important attempt to extend the 
frailty issue to neuropsychological correlates taking in consid-
eration a multidimensional approach These findings suggest that 
the assessment of pre-frailty conditions must be achieved quan-
titatively by means of a multidimensional approach to clarify 
the nature and correlates of this multifaceted phenomenon. 
In particular, the impact of everyday executive dysfunction, 
early changes in mood and the awareness of iADL disabilities 
must be considered. Our results benefit from the homogene-
ity of the experimental sample in terms of etiopathogenetic 
mechanisms, disease severity (CDR) and functionality in daily 
life (ADL/iADL). The evaluation of pre-frailty conditions and 
their neuropsychological correlates is clinically relevant. Indeed, 
this multifaceted phenomenon has diagnostic, nosological, and 
prognostic implications that may affect patients’ wellbeing in the 
continuum from MCI to AD.
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